Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (13140)	8/13/1998 1:40:00 PM
From: BigKNY3	Read Replies (2) \| Respond to of 23519

Vlad: << BTW Joe K on CNBS just discussed that PFE is down on the vision news--in typical proPfizer/antiVivus slant he incorrectly explained that he guessed it was due to a report that in CDV patients there was a temporary loss of vision. As I read the WSJ it was a PERMANENT loss of vision. Damn big difference but in classic CNBC slanted style again the public is deceived. >> Vlad: I would suggest rereading the article. Based on the below abbreviated highlights, Joe K's report on the article appears accurate. BigKNY3 ________________________________ Some Viagra Users Temporarily Lost Vision, Reports Say By Rochelle Sharpe Staff Reporter of The Wall Street Journal WASHINGTON -- Some men with cardiovascular problems temporarily lost their vision after taking Viagra, according to new reports about the impotence pill's side effects. "It's impossible to know whether there's any relation to Viagra," said Alan Laties, a consultant to Viagra manufacturer Pfizer Inc. and an ophthalmology professor at the University of Pennsylvania Medical School. But the handful of eye reports touch on the potential problems that can occur if men with cardiovascular disease resume intercourse using Viagra. If these men strain their hearts during sex, blood vessels anywhere in their bodies could be stressed -- including in their eyes, said Michael Marmor, an ophthalmology professor at Stanford University. The eye problems are "the ocular equivalent of having a small stroke or small heart attack," he said. Pfizer has said that in clinical trials, about 3% of Viagra users have reported temporarily seeing a bluish tinge after taking the drug, and studies are continuing. Ophthalmologists are concerned that the drug may chemically affect the eye because the drug blocks an enzyme found in the retina. But none of the reports indicates that Viagra is having a direct chemical effect on the eye, Dr. Marmor said. "This complication is more likely to be a report of patients' underlying cardiovascular disease," he said.